| Product Code: ETC6198958 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Clinical Oncology Next Generation Sequencing Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Clinical Oncology Next Generation Sequencing Market - Industry Life Cycle |
3.4 Austria Clinical Oncology Next Generation Sequencing Market - Porter's Five Forces |
3.5 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Austria Clinical Oncology Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Austria |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in next generation sequencing (NGS) technology |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Lack of skilled professionals to interpret NGS data |
4.3.3 Regulatory challenges and reimbursement issues |
5 Austria Clinical Oncology Next Generation Sequencing Market Trends |
6 Austria Clinical Oncology Next Generation Sequencing Market, By Types |
6.1 Austria Clinical Oncology Next Generation Sequencing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Targeted Sequencing, 2021- 2031F |
6.1.6 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Resequencing, 2021- 2031F |
6.2 Austria Clinical Oncology Next Generation Sequencing Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Pre-Sequencing, 2021- 2031F |
6.2.3 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Sequencing, 2021- 2031F |
6.2.4 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.3 Austria Clinical Oncology Next Generation Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Austria Clinical Oncology Next Generation Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.4.5 Austria Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Austria Clinical Oncology Next Generation Sequencing Market Import-Export Trade Statistics |
7.1 Austria Clinical Oncology Next Generation Sequencing Market Export to Major Countries |
7.2 Austria Clinical Oncology Next Generation Sequencing Market Imports from Major Countries |
8 Austria Clinical Oncology Next Generation Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing in clinical oncology |
8.2 Adoption rate of NGS testing in oncology clinics |
8.3 Number of clinical trials incorporating NGS technology |
8.4 Rate of innovation in NGS technology for oncology applications |
8.5 Patient outcomes and survival rates post-NGS guided treatment |
9 Austria Clinical Oncology Next Generation Sequencing Market - Opportunity Assessment |
9.1 Austria Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Austria Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Austria Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Austria Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Austria Clinical Oncology Next Generation Sequencing Market - Competitive Landscape |
10.1 Austria Clinical Oncology Next Generation Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Austria Clinical Oncology Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here